Literature DB >> 1772299

Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.

A M Cilursu1, J Goeken, R R Olson.   

Abstract

The Center for Disease Control has received numerous reports of an eosinophilia-myalgia syndrome related to products containing L-tryptophan. The case is reported of eosinophilia-myalgia syndrome and polyneuropathy associated with myeloperoxidase specific antineutrophil cytoplasmic antibody.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772299      PMCID: PMC1004566          DOI: 10.1136/ard.50.11.817

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

Authors:  J W Tervaert; F J van der Woude; A S Fauci; J L Ambrus; J Velosa; W F Keane; S Meijer; M van der Giessen; G K van der Hem; T H The
Journal:  Arch Intern Med       Date:  1989-11

2.  Neutrophil cytoplasmic autoantibodies and Wegener's granulomatosis.

Authors: 
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

3.  Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis.

Authors:  C O Savage; C G Winearls; S Jones; P D Marshall; C M Lockwood
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

4.  Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase.

Authors:  J L Niles; R T McCluskey; M F Ahmad; M A Arnaout
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

5.  Circulating anti-neutrophil cytoplasm antibodies in patients with rapidly progressive glomerulonephritis and extracapillary proliferation.

Authors:  L Nässberger; A G Sjöholm; P Bygren; H Thysell; M Højer-Madsen; N Rasmussen
Journal:  J Intern Med       Date:  1989-03       Impact factor: 8.989

6.  Vasculitis complicating cystic fibrosis.

Authors:  M J Finnegan; J Hinchcliffe; D Russell-Jones; S Neill; E Sheffield; D Jayne; A Wise; M E Hodson
Journal:  Q J Med       Date:  1989-07

7.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

8.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

Review 9.  Antineutrophil cytoplasmic autoantibodies and associated diseases: a review.

Authors:  J C Jennette; R J Falk
Journal:  Am J Kidney Dis       Date:  1990-06       Impact factor: 8.860

10.  Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis.

Authors:  J C Jennette; A S Wilkman; R J Falk
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

View more
  4 in total

1.  Antineutrophil cytoplasmic antibodies and the eosinophilia myalgia syndrome.

Authors:  A Schnabel; W L Gross; P A Berg; R Klein; H Lehnert
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

2.  Eosinophilia-myalgia syndrome: selective cognitive impairment, longitudinal effects, and neuroimaging findings.

Authors:  C Armstrong; T Lewis; M D'Esposito; B Freundlich
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-11       Impact factor: 10.154

3.  Microscopic polyangiitis initiated with liver dysfunction, calf pain and fever of unknown origin.

Authors:  Kei Ohnuma; Osamu Hosono; Tomoki Katayose; Noritada Yoshikawa; Hiroshi Kawasaki; Takeshi Fujii; Naoki Oyaizu; Hirotoshi Tanaka; Chikao Morimoto
Journal:  Rheumatol Int       Date:  2009-09-23       Impact factor: 2.631

Review 4.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.